Director Kroll Mark W bought Haemonetics Corp ($HAE) shares once on the open market in the last year for nearly $99,000. His latest purchase occurred on November 10, 2025. Among 4,983 insiders, this ranks 2,378th for purchase value, below the average of $1.5 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 10, 2025 | HAEMONETICS CORP | $HAE | KROLL MARK W | Director | P | Common Stock | 1400 | $70.56 | 24,757.0000 | 48,009,000 | 5.99% | 0.00% |
| July 24, 2025 | HAEMONETICS CORP | $HAE | KROLL MARK W | Director | A | Common Stock | 2693 | $0.00 | 23,357.0000 | 50,730,000 | 13.03% | 0.01% |
| July 25, 2024 | HAEMONETICS CORP | $HAE | KROLL MARK W | Director | A | Common Stock | 2207 | $0.00 | 20,664.0000 | 51,397,000 | 11.96% | 0.00% |
| May 12, 2023 | AXON ENTERPRISE, INC. | $AXON | KROLL MARK W | Not found | A | Common Stock | 993 | $0.00 | 11,135.0000 | 72,534,000 | 9.79% | 0.00% |
| March 7, 2023 | AXON ENTERPRISE, INC. | $AXON | KROLL MARK W | Not found | S | Common Stock | 92 | $220.85 | 13,599.0000 | 72,534,000 | 0.67% | 0.00% |
| March 7, 2023 | AXON ENTERPRISE, INC. | $AXON | KROLL MARK W | Not found | S | Common Stock | 3457 | $220.72 | 10,142.0000 | 72,534,000 | 25.42% | 0.00% |